HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 89 | 96 | 92.7% | |
| HF004 | 2020 | 159 | 169 | 94.1% | |
| HF006 | 2021 | 193 | 213 | 90.6% | |
| HF006 | 2022 | 581 | 632 | 91.9% | |
| HF006 | 2023 | 571 | 593 | 96.3% |
